Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FGFR1 oncogene partner 2 pseudogene (FGFR1OP2P)
- Target
- FGFR1OP2P
- Molecular classification
- Other (Pseudogene; not an enzyme, receptor, transporter, channel, or transcription factor)
01
Overview
FGFR1 oncogene partner 2 pseudogene (ENSG00000257954) is a pseudogene sequence related to the protein-coding FGFR1OP2 gene[1][3]. Unlike FGFR1OP2, which has been observed in fusion events with FGFR1 leading to constitutive kinase activity implicated in myeloproliferative syndrome and possibly involved in wound healing, the pseudogene variant does not produce a protein and has no known biological function or disease association itself[1][3][6]. Pseudogenes are non-functional relatives of protein-coding genes arising from duplication or retrotransposition, and as such, FGFR1 oncogene partner 2 pseudogene is not considered a valid molecular or therapeutic target nor implicated in human disease, drug interactions, or clinical biomarker use[1][3][6]. This gene entry should not be used in therapeutic, diagnostic, or mechanistic contexts. It is important to note the difference between this pseudogene and the related protein-coding FGFR1OP2 gene, which may have functional importance in some disease settings[1][3][6].
- Other names
- FGFR1OP2PFGFR1 oncogene partner 2 pseudogeneFGFR1OP2P1
Beyond the preview
Go deeper on FGFR1 oncogene partner 2 pseudogene (FGFR1OP2P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FGFR1 oncogene partner 2 pseudogene (FGFR1OP2P).